{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:10:05Z","timestamp":1777396205236,"version":"3.51.4"},"reference-count":98,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,4,7]]},"DOI":"10.3233\/jad-191091","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T08:04:57Z","timestamp":1582272297000},"page":"883-901","source":"Crossref","is-referenced-by-count":19,"title":["Oxytocin Alleviates MPTP-Induced Neurotoxicity in Mice by Targeting MicroRNA-26a\/Death-Associated Protein Kinase 1 Pathway"],"prefix":"10.1177","volume":"74","author":[{"given":"Hasan A.M.M.","family":"Almansoub","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"Department of Biology, Faculty of Science \u2013 Marib, Sana\u2019a University, Marib, Yemen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yacoubou Abdoul Razak","family":"Mahaman","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"Department of Cognitive Impairment Ward of Neurology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maibouge Tanko Mahamane","family":"Salissou","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youming","family":"Lu","sequence":"additional","affiliation":[{"name":"The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan-Ting","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"The Institute of Brain Research, Collaborative Innovation Center for Brain Science, Huazhong University of Science and Technology, Wuhan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusra A.M.","family":"Almansob","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Key lab of a neurological disorder of Education Ministry, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"},{"name":"Department of Genetics, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-191091_ref1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: Mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-191091_ref2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson\u2019s disease: Animal models and dopaminergic cell vulnerability","volume":"8","author":"Blesa","year":"2014","journal-title":"Front Neuroanat"},{"key":"10.3233\/JAD-191091_ref3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3233\/JAD-190870","article-title":"Bergenin ameliorates MPTP-induced Parkinson\u2019s disease by activating PI3K\/Akt signaling pathway","volume":"72","author":"Ji","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-191091_ref4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0079-6123(08)64021-2","article-title":"Neuropathological hallmarks of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"117","author":"Braak","year":"1998","journal-title":"Prog Brain Res"},{"key":"10.3233\/JAD-191091_ref5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson\u2019s disease: Focus on pharmacological interventions targeting affective dysfunctions","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.3233\/JAD-191091_ref6","doi-asserted-by":"crossref","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","article-title":"A guide to neurotoxic animal models of Parkinson\u2019s disease","volume":"1","author":"Tieu","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-191091_ref7","doi-asserted-by":"crossref","first-page":"e3135","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"3","author":"Tsigelny","year":"2008","journal-title":"PLoS One"},{"key":"10.3233\/JAD-191091_ref8","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1100\/2011\/371893","article-title":"Interaction between alpha-synuclein and other proteins in neurodegenerative disorders","volume":"11","author":"Jellinger","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"10.3233\/JAD-191091_ref9","doi-asserted-by":"crossref","first-page":"e26609","DOI":"10.1371\/journal.pone.0026609","article-title":"Tau enhances alpha-synuclein aggregation and toxicity in cellular models of synucleinopathy","volume":"6","author":"Badiola","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-191091_ref10","doi-asserted-by":"crossref","first-page":"32656","DOI":"10.1038\/srep32656","article-title":"Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson\u2019s disease model induced by MPTP","volume":"6","author":"Filichia","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-191091_ref11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP mouse models of Parkinson\u2019s disease: An update","volume":"1","author":"Meredith","year":"2011","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JAD-191091_ref12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson\u2019s disease: An empirical comparison with the phenomenology of the disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-191091_ref13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0922-4106(91)90073-Q","article-title":"MPTP mechanisms of neurotoxicity and their implications for Parkinson\u2019s disease","volume":"208","author":"Gerlach","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-191091_ref14","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1096\/fj.06-6092com","article-title":"Alpha-synuclein induces hyperphosphorylation of tau in the MPTP model of parkinsonism","volume":"20","author":"Duka","year":"2006","journal-title":"FASEB J"},{"key":"10.3233\/JAD-191091_ref15","doi-asserted-by":"crossref","DOI":"10.1177\/1759091418777438","article-title":"Neurotoxin-induced animal models of Parkinson disease: Pathogenic mechanism and assessment","volume":"10","author":"Zeng","year":"2018","journal-title":"ASN Neuro"},{"key":"10.3233\/JAD-191091_ref16","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","article-title":"Neurochemical findings in the MPTP model of Parkinson\u2019s disease","volume":"108","author":"Schmidt","year":"2001","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-191091_ref17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.3233\/JAD-191091_ref18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","article-title":"MicroRNA-26a\/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson\u2019s disease","volume":"85","author":"Su","year":"2019","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-191091_ref19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4149\/gpb_2013055","article-title":"Suppression of exaggerated neuronal oscillations by oxytocin in a rat model of Parkinson\u2019s disease","volume":"32","author":"Erbas","year":"2013","journal-title":"Gen Physiol Biophys"},{"key":"10.3233\/JAD-191091_ref20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fendo.2015.00076","article-title":"Oxytocin during development: Possible organizational effects on behavior","volume":"6","author":"Miller","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.3233\/JAD-191091_ref21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10571-012-9799-1","article-title":"Effect of oxytocin on neuroblastoma cell viability and growth","volume":"32","author":"Bakos","year":"2012","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-191091_ref22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hipo.20947","article-title":"Oxytocin stimulates adult neurogenesis even under conditions of stress and elevated glucocorticoids","volume":"22","author":"Leuner","year":"2012","journal-title":"Hippocampus"},{"key":"10.3233\/JAD-191091_ref23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pbb.2013.11.019","article-title":"Oxytocin in learning and addiction: From early discoveries to the present","volume":"119","author":"Sarnyai","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-191091_ref24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.31887\/DCNS.2015.17.4\/pkirsch","article-title":"Oxytocin in the socioemotional brain: Implications for psychiatric disorders","volume":"17","author":"Kirsch","year":"2015","journal-title":"Dialogues Clin Neurosci"},{"key":"10.3233\/JAD-191091_ref25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1037\/a0031581","article-title":"Effects of a 10-day oxytocin trial in older adults on health and well-being","volume":"21","author":"Barraza","year":"2013","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.3233\/JAD-191091_ref26","first-page":"7216","article-title":"Intranasal spray of oxytocin might improve working memory performance in Alzheimer, tracking with diffusion tensor imaging","volume":"9","author":"Bakouie","year":"2018","journal-title":"Biomed J Sci Tech Res"},{"key":"10.3233\/JAD-191091_ref27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.schres.2014.12.029","article-title":"The effects of a single dose of oxytocin on working memory in schizophrenia","volume":"162","author":"Michalopoulou","year":"2015","journal-title":"Schizophr Res"},{"key":"10.3233\/JAD-191091_ref28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-191091_ref29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jnc.13409","article-title":"Chronic and progressive Parkinson\u2019s disease MPTP model in adult and aged mice","volume":"136","author":"Munoz-Manchado","year":"2016","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-191091_ref30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JPD-181503","article-title":"Semaglutide is neuroprotective and reduces alpha-synuclein levels in the chronic MPTP mouse model of Parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JAD-191091_ref31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.3233\/JAD-191091_ref32","doi-asserted-by":"crossref","first-page":"e12902","DOI":"10.1111\/acel.12902","article-title":"Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer\u2019s disease via C\/EBPalpha\/miR-125b pathway","volume":"18","author":"Tang","year":"2019","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-191091_ref33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.biopsych.2017.07.023","article-title":"A novel microRNA-124\/PTPN1 signal pathway mediates synaptic and memory deficits in Alzheimer\u2019s disease","volume":"83","author":"Wang","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-191091_ref34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1471-4159.2001.00066.x","article-title":"Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells","volume":"76","author":"De Girolamo","year":"2001","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-191091_ref35","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.18632\/aging.101627","article-title":"Methanolic extract of Tamarix Gallica attenuates hyperhomocysteinemia induced AD-like pathology and cognitive impairments in rats","volume":"10","author":"Salissou","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.3233\/JAD-191091_ref36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3233\/JAD-180091","article-title":"Moringa oleifera alleviates homocysteine-induced Alzheimer\u2019s disease-like pathology and cognitive impairments","volume":"63","author":"Mahaman","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-191091_ref37","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1007\/s12035-015-9421-x","article-title":"Cnga2 knockout mice display Alzheimer\u2019s-like behavior abnormities and pathological changes","volume":"53","author":"Xie","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-191091_ref38","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ymthe.2017.01.018","article-title":"Targeting the HDAC2\/HNF-4A\/miR-101b\/AMPK pathway rescues tauopathy and dendritic abnormalities in Alzheimer\u2019s disease","volume":"25","author":"Liu","year":"2017","journal-title":"Mol Ther"},{"key":"10.3233\/JAD-191091_ref39","first-page":"4115","article-title":"The lesion analysis of cholinergic neurons in 5XFAD mouse model in the three-dimensional level of whole brain","volume":"55","author":"Yan","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-191091_ref40","doi-asserted-by":"crossref","first-page":"e12929","DOI":"10.1111\/acel.12929","article-title":"Tau overexpression impairs neuronal endocytosis by decreasing the GTPase dynamin 1 through the miR-132\/MeCP2 pathway","volume":"18","author":"Xie","year":"2019","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-191091_ref41","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3109\/13880209.2014.993041","article-title":"Ferulic acid pretreatment mitigates MPTP-induced motor impairment and histopathological alterations in C57BL\/6 mice","volume":"53","author":"Nagarajan","year":"2015","journal-title":"Pharm Biol"},{"key":"10.3233\/JAD-191091_ref42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4196\/kjpp.2013.17.1.89","article-title":"Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on motor behavior and dopamine levels at brain regions in three different mouse strains","volume":"17","author":"Lee","year":"2013","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.3233\/JAD-191091_ref43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fnagi.2018.00162","article-title":"Cdk5 inhibitory peptide prevents loss of dopaminergic neurons and alleviates behavioral changes in an MPTP induced Parkinson\u2019s disease mouse model","volume":"10","author":"He","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-191091_ref44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","article-title":"Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury","volume":"32","author":"Vuckovic","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-191091_ref45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fnbeh.2013.00175","article-title":"Rodent models of Parkinson\u2019s disease: Beyond the motor symptomatology","volume":"7","author":"Campos","year":"2013","journal-title":"Front Behav Neurosci"},{"key":"10.3233\/JAD-191091_ref46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","article-title":"Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains","volume":"240","author":"Walker","year":"2013","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-191091_ref47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":"alpha-synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-191091_ref48","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/mds.20391","article-title":"Alpha-synuclein mRNA expression in sporadic Parkinson\u2019s disease","volume":"20","author":"Tan","year":"2005","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-191091_ref49","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-191091_ref50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.3233\/JAD-191091_ref51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mds.22096","article-title":"Clinical and pathological characteristics of patients with leucine-rich repeat kinase-2 mutations","volume":"24","author":"Covy","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-191091_ref52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1155\/S1110724302203010","article-title":"Alzheimer disease and oxidative stress","volume":"2","author":"Perry","year":"2002","journal-title":"J Biomed Biotechnol"},{"key":"10.3233\/JAD-191091_ref53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JAD-191091_ref54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson\u2019s disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-191091_ref55","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1248\/bpb.b14-00128","article-title":"Protective effect of chinonin in MPTP-induced C57BL\/6 mouse model of Parkinson\u2019s disease","volume":"37","author":"Feng","year":"2014","journal-title":"Biol Pharm Bull"},{"key":"10.3233\/JAD-191091_ref56","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1021\/pr101211k","article-title":"Alterations in the mitochondrial proteome of neuroblastoma cells in response to complex 1 inhibition","volume":"10","author":"Burte","year":"2011","journal-title":"J Proteome Res"},{"key":"10.3233\/JAD-191091_ref57","doi-asserted-by":"crossref","first-page":"12178","DOI":"10.1038\/s41598-017-12379-3","article-title":"CIB1 protects against MPTP-induced neurotoxicity through inhibiting ASK1","volume":"7","author":"Yoon","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-191091_ref58","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","article-title":"Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice","volume":"12","author":"Muralikrishnan","year":"1998","journal-title":"FASEBJ"},{"key":"10.3233\/JAD-191091_ref59","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1471-4159.1996.66020658.x","article-title":"Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentrations and release","volume":"66","author":"Dluzen","year":"1996","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-191091_ref60","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6","article-title":"Apomorphine protects against MPTP-induced neurotoxicity in mice","volume":"14","author":"Grunblatt","year":"1999","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-191091_ref61","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s007020170018","article-title":"Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: Comparison of rasagiline (TVP 1012) with selegiline","volume":"108","author":"Kupsch","year":"2001","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-191091_ref62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.44.1.84","article-title":"Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson\u2019s disease","volume":"44","author":"Purba","year":"1994","journal-title":"Neurology"},{"key":"10.3233\/JAD-191091_ref63","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neuron.2017.06.003","article-title":"Biased oxytocinergic modulation of midbrain dopamine systems","volume":"95","author":"Xiao","year":"2017","journal-title":"Neuron"},{"key":"10.3233\/JAD-191091_ref64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4183\/aeb.2016.65","article-title":"Is oxytocin relevant for the affective disorders?","volume":"12","author":"Ciobica","year":"2016","journal-title":"Acta Endocrinol (Buchar)"},{"key":"10.3233\/JAD-191091_ref65","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijvsm.2017.08.003","article-title":"Describing some behavioural animal models of anxiety and their mechanistics with special reference to oxidative stress and oxytocin relevance","volume":"5","author":"Padurariu","year":"2017","journal-title":"Int J Vet Sci Med"},{"key":"10.3233\/JAD-191091_ref66","first-page":"924605","article-title":"Bladder, bowel, and sexual dysfunction in Parkinson\u2019s disease","volume":"2011","author":"Sakakibara","year":"2011","journal-title":"Parkinsons Dis"},{"key":"10.3233\/JAD-191091_ref67","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.37.6.1001","article-title":"Oxytocin in Alzheimer\u2019s disease: Postmortem brain levels","volume":"37","author":"Mazurek","year":"1987","journal-title":"Neurology"},{"key":"10.3233\/JAD-191091_ref68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1573406411666151030112140","article-title":"miRNAs as circulating biomarkers for Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"12","author":"Mushtaq","year":"2016","journal-title":"Med Chem"},{"key":"10.3233\/JAD-191091_ref69","doi-asserted-by":"crossref","first-page":"e25443","DOI":"10.1371\/journal.pone.0025443","article-title":"Convergence of miRNA expression profiling, alpha-synuclein interacton and GWAS in Parkinson\u2019s disease","volume":"6","author":"Martins","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-191091_ref70","doi-asserted-by":"crossref","first-page":"34644","DOI":"10.1074\/jbc.M506466200","article-title":"Death-associated protein kinase as a sensor of mitochondrial membrane potential: Role of lysosome in mitochondrial toxin-induced cell death","volume":"280","author":"Shang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-191091_ref71","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1083\/jcb.200109094","article-title":"DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death","volume":"157","author":"Inbal","year":"2002","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-191091_ref72","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.0711053105","article-title":"The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease","volume":"105","author":"Gorbatyuk","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-191091_ref73","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"Chen","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-191091_ref74","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","article-title":"Neurodegenerative diseases and oxidative stress","volume":"58","author":"Emerit","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.3233\/JAD-191091_ref75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-191091_ref76","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11062-019-09785-w","article-title":"Effects of oxytocin administration on oxidative markers in the temporal lobe of aged rats","volume":"51","author":"Balmus","year":"2019","journal-title":"Neurophysiology"},{"key":"10.3233\/JAD-191091_ref77","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biopha.2011.07.001","article-title":"Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity","volume":"65","author":"Rashed","year":"2011","journal-title":"Biomed Pharmacother"},{"key":"10.3233\/JAD-191091_ref78","doi-asserted-by":"crossref","first-page":"E1495","DOI":"10.1152\/ajpendo.90718.2008","article-title":"Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells","volume":"295","author":"Szeto","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3233\/JAD-191091_ref79","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biopha.2018.07.148","article-title":"Oxytocin improves animal behaviors and ameliorates oxidative stress and inflammation in autistic mice","volume":"107","author":"Wang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.3233\/JAD-191091_ref80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneumeth.2007.03.021","article-title":"A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: Pharmacological validation with R-(\u2013)-deprenyl","volume":"164","author":"Quinn","year":"2007","journal-title":"J Neurosci Methods"},{"key":"10.3233\/JAD-191091_ref81","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/bjp.2008.78","article-title":"The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson\u2019s disease through inhibition of monoamine oxidase B","volume":"154","author":"Quinn","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-191091_ref82","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/syn.890150107","article-title":"Dopamine transporter mutants selectively enhance MPP+transport","volume":"15","author":"Kitayama","year":"1993","journal-title":"Synapse"},{"key":"10.3233\/JAD-191091_ref83","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1523\/JNEUROSCI.13-10-04246.1993","article-title":"Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium","volume":"13","author":"Pifl","year":"1993","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-191091_ref84","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/neur.1996.0041","article-title":"The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse","volume":"5","author":"German","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.3233\/JAD-191091_ref85","first-page":"691","article-title":"Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice","volume":"257","author":"Giovanni","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-191091_ref86","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-8993(87)90986-3","article-title":"Studies on the effect of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57 BL\/6 mice. Comparison with three other strains of mice","volume":"405","author":"Sunstro","year":"1987","journal-title":"Brain Res"},{"key":"10.3233\/JAD-191091_ref87","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","article-title":"MPTP susceptibility in the mouse: Behavioral, neurochemical, and histological analysis of gender and strain differences","volume":"30","author":"Sedelis","year":"2000","journal-title":"Behav Genet"},{"key":"10.3233\/JAD-191091_ref88","doi-asserted-by":"crossref","first-page":"e00290","DOI":"10.1002\/prp2.290","article-title":"Structure-specific effects of lipidated oxytocin analogs on intracellular calcium levels, parental behavior, and oxytocin concentrations in the plasma and cerebrospinal fluid in mice","volume":"5","author":"Cherepanov","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"10.3233\/JAD-191091_ref89","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-191091_ref90","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"10.3233\/JAD-191091_ref91","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1038\/tp.2016.1","article-title":"Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson\u2019s disease","volume":"6","author":"Lauretti","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-191091_ref92","doi-asserted-by":"crossref","first-page":"e60378","DOI":"10.1371\/journal.pone.0060378","article-title":"Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function","volume":"8","author":"Oaks","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-191091_ref93","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3758\/s13415-014-0253-3","article-title":"Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"14","author":"Pietropaolo","year":"2014","journal-title":"Cogn Affect Behav Neurosci"},{"key":"10.3233\/JAD-191091_ref94","doi-asserted-by":"crossref","first-page":"1238687","DOI":"10.1155\/2017\/1238687","article-title":"Citalopram ameliorates impairments in spatial memory and synaptic plasticity in female 3xTgAD mice","volume":"2017","author":"Wei","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.3233\/JAD-191091_ref95","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jss.2012.11.043","article-title":"Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with experimentally induced sepsis","volume":"183","author":"Erbas","year":"2013","journal-title":"J Surg Res"},{"key":"10.3233\/JAD-191091_ref96","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jss.2005.01.021","article-title":"Oxytocin protects against sepsis-induced multiple organ damage: Role of neutrophils","volume":"126","author":"Iseri","year":"2005","journal-title":"J Surg Res"},{"key":"10.3233\/JAD-191091_ref97","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0196-9781(01)00469-7","article-title":"Oxytocin decreases carrageenan induced inflammation in rats","volume":"22","author":"Petersson","year":"2001","journal-title":"Peptides"},{"key":"10.3233\/JAD-191091_ref98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.peptides.2012.03.023","article-title":"Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: Role of mitochondrial ATP-dependent potassium channel and permeability transition pore","volume":"36","author":"Alizadeh","year":"2012","journal-title":"Peptides"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-191091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:47Z","timestamp":1777370867000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-191091"}},"subtitle":[],"editor":[{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":98,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-191091","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]}}}